RAP 0.00% 20.5¢ resapp health limited

If they are knocking back a De Novo application (probably the...

  1. 18,579 Posts.
    lightbulb Created with Sketch. 2630
    If they are knocking back a De Novo application (probably the easiest path to get through), you really have to ask what are the issues here.

    Is the product Not similar to an existing product already approved?

 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.